XML 34 R21.htm IDEA: XBRL DOCUMENT v3.22.2
SHAREHOLDERS' EQUITY (Tables) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Equity [Abstract]        
Schedule of Accumulated Other Comprehensive Income (Loss)  
A roll forward of the amounts included in accumulated other comprehensive loss, net of tax (in millions), is shown below for the three and six months ended June 30, 2022:
Marketable SecuritiesEmployee Benefit PlanInterest Rate DerivativesTotal
Balance at March 31, 2022, net of tax effect of $93
$(44)$(251)$$(292)
Reclassifications into earnings, net of tax impact of $1
— — 
Change in value, net of tax impact of $4
(22)— (18)
Balance at June 30, 2022, net of tax effect of $98
$(64)$(251)$7 $(308)
Balance at December 31, 2021, net of tax effect of $83
$(4)$(252)$(6)$(262)
Reclassifications into earnings, net of tax impact of $1
— 
Change in value, net of tax impact of $14
(64)— 13 (51)
Balance at June 30, 2022, net of tax effect of $98
$(64)$(251)$7 $(308)
   
Related to marketable securities $ (308) $ (308) $ (292) $ (262)
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax 2 5    
OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax (18) $ (51)    
Schedule of Stockholders' Equity Note, Warrants or Rights   Total warrants outstanding are as follows as of June 30, 2022:
Number of warrants outstandingStrike Price
PSP 1928,127 31.61
CARES Act loan warrants427,080 31.61
PSP 2305,499 52.25
PSP 3221,812 66.39
Outstanding June 30, 20221,882,518 
   
Related to marketable securities $ (308) $ (308) $ (292) $ (262)